AU2002222753A1 - Compositions for inducing secretion of insulin-like growth factor-1 - Google Patents

Compositions for inducing secretion of insulin-like growth factor-1

Info

Publication number
AU2002222753A1
AU2002222753A1 AU2002222753A AU2275302A AU2002222753A1 AU 2002222753 A1 AU2002222753 A1 AU 2002222753A1 AU 2002222753 A AU2002222753 A AU 2002222753A AU 2275302 A AU2275302 A AU 2275302A AU 2002222753 A1 AU2002222753 A1 AU 2002222753A1
Authority
AU
Australia
Prior art keywords
insulin
compositions
growth factor
inducing secretion
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222753A
Inventor
Jae-Soo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naturalendo Tech Co Ltd
Original Assignee
Naturalendo Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020010065100A external-priority patent/KR20020046923A/en
Application filed by Naturalendo Tech Co Ltd filed Critical Naturalendo Tech Co Ltd
Publication of AU2002222753A1 publication Critical patent/AU2002222753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2002222753A 2000-12-15 2001-12-14 Compositions for inducing secretion of insulin-like growth factor-1 Abandoned AU2002222753A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
KR0077121 2000-12-15
KR20000077121 2000-12-15
KR0155519 2001-09-10
KR20010055519 2001-09-10
KR0165100 2001-10-22
KR1020010065100A KR20020046923A (en) 2000-12-15 2001-10-22 Pharmaceutical Compositions and Health Foods for IGF-1 Release Comprising Extract from Phlomis umbrosa
PCT/KR2001/002170 WO2002047702A1 (en) 2000-12-15 2001-12-14 Compositions for inducing secretion of insulin-like growth factor-1

Publications (1)

Publication Number Publication Date
AU2002222753A1 true AU2002222753A1 (en) 2002-06-24

Family

ID=27350371

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222753A Abandoned AU2002222753A1 (en) 2000-12-15 2001-12-14 Compositions for inducing secretion of insulin-like growth factor-1

Country Status (5)

Country Link
US (1) US6984405B1 (en)
EP (1) EP1349559B1 (en)
JP (1) JP2004518647A (en)
AU (1) AU2002222753A1 (en)
WO (1) WO2002047702A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100382040B1 (en) 2002-08-06 2003-04-26 Naturalendo Tech Co Ltd Composition for stimulating estrogen secretion and regenerating female reproductive tissue cells
KR100406837B1 (en) * 2002-10-14 2003-11-21 Natural Endotech Co Ltd Health food composition containing natural product extract for reducing blood glucose level through the promotion of insulin release
JP2007031375A (en) * 2005-07-28 2007-02-08 Kyowa Hakko Kogyo Co Ltd Oral agent for ameliorating skin quality
JP2009256270A (en) * 2008-04-18 2009-11-05 Maruzen Pharmaceut Co Ltd Insulin-like growth factor-1 expression promoting agent
KR101106110B1 (en) * 2009-03-23 2012-01-18 (주)내츄럴엔도텍 Compositions for Preventing or Treating Insomnia
TWI504394B (en) 2011-04-29 2015-10-21 Ind Tech Res Inst Method for preparing antofine
JP6126443B2 (en) * 2012-06-08 2017-05-10 花王株式会社 Skeletal muscle retarder
KR101189605B1 (en) * 2012-06-28 2012-10-11 홍상근 White pleuropterus multiflorus and phlomis umbrosa extract for promoting insulin-like growth factor secretion and bone framework growth, and method for producing the same
CA2888811C (en) * 2012-10-22 2023-10-24 University Of Southern California A diet package, and uses thereof
KR101794607B1 (en) * 2015-07-10 2017-11-07 주식회사 브레인온 A composition for promoting exercise activity and muscle comprising a Dipsaci Radix and a Cynanchum wilfordii Radix extract
JP6615589B2 (en) * 2015-11-13 2019-12-04 日本メナード化粧品株式会社 Stem cell undifferentiated state maintenance agent and growth promoter
KR102501845B1 (en) * 2021-02-08 2023-02-20 경희대학교 산학협력단 Composition for skin regeneration and wound healing comprising the extract of Cynanchum wilfordii as an active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU904710A1 (en) 1980-05-23 1982-02-15 Курский Государственный Медицинский Институт Method of producing sum of flavonoids, iridoids and hydroxycinnamic acids
US5861373A (en) 1991-08-01 1999-01-19 Genentech, Inc IGF-1 to improve the neural condition
SE9201573D0 (en) 1992-05-19 1992-05-19 Kabi Pharmacia Ab USE OF IGF-1
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
JPH0725777A (en) 1993-07-14 1995-01-27 Tsumura & Co Synthesis promoter for neurotrophy factor
CN1064841C (en) 1995-07-20 2001-04-25 白侍儒 Bone injury tincture
JP3041232B2 (en) * 1995-11-16 2000-05-15 日本ケミカルリサーチ株式会社 Cancer metastasis inhibitor
CN1099840C (en) * 1997-11-28 2003-01-29 金东秀 Crude drug composition for feed addition for improving cultivation of fish grow

Also Published As

Publication number Publication date
EP1349559A1 (en) 2003-10-08
WO2002047702A1 (en) 2002-06-20
US6984405B1 (en) 2006-01-10
JP2004518647A (en) 2004-06-24
EP1349559B1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
AU2002233929A1 (en) Compositions of peptide crystals
AU2001273034A1 (en) Composition for delivery of hematopoietic growth factor
AU2001245660A1 (en) Embolic compositions
AU2093101A (en) Compositions for efficient release of active ingredients
AU2001233081A1 (en) Composition for treatment of stress
AU2001236632A1 (en) Extraction of growth factors from tissue
AU2001248742A1 (en) Compositions for promoting sleep
AU2002222753A1 (en) Compositions for inducing secretion of insulin-like growth factor-1
AU2001295939A1 (en) Process for preparation of polyisocyanate composition
AU2002361960A1 (en) Growth promoter composition for animals
AU2002338709A1 (en) Workability-improving agents for cement compositions
AU2001245764A1 (en) Novel compounds and compositions as protease inhibitors
AU2002224525A1 (en) Compositions for regulating desire for smoking
AUPQ579800A0 (en) Plant growth hormone compositions
AU2002246619A1 (en) Use of insuline-like growth factor-i for promoting remyelination of axons
AU2002217071A1 (en) Novel use of polyhydroxy compounds
AU2001240557A1 (en) Implant for cranioplastics
AU2001244108A1 (en) Formulations for states of dehydration
AU2001251640A1 (en) Lice remover composition
AU2002328944A1 (en) Additives for cement compositions
AU2001238540A1 (en) Non-aqueous injectable formulations for extended release of somatotropin
AU2001264295A1 (en) Compositions for preventing urinary calculus
AU2001284496A1 (en) Insulin secretion controlling agents
AU6650901A (en) Composition for inhibiting feeding of weevils
AU2002238778A1 (en) Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics